Flossmoor resident and cancer survivor Ann Jackson launched the Center for Food Equity in Medicine at Flossmoor Community ...
The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...
Patients with HER-2 positive early breast cancer with residual invasive disease after neoadjuvant therapy were randomly ...
The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...
Even if a patient is unable to beat the disease, early-stage detection of cancer can play a crucial role in increasing their ...
Patient outcomes appeared to be more heavily driven by breast cancer stage than delays in diagnosis, researchers found.
Heart disease increases the likelihood of advanced breast cancer. Hormone receptor-positive tumors are linked to ...
A new analysis of the Breast Cancer Index (BCI) may help identify women with HR-positive breast cancer who could potentially ...
Sharni Marks, 31, was added to the waiting list in August 2022 without a specified surgery date. Despite being repeatedly informed she was a priority for the operation, it wasn't until March 2024 that ...